Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Marks

Showing results (351-360 of 358) with videos related to

Pageof 36
Sort By:
You have reached the last page of results.This site can display upto 358 results.
Ebiomedicine|January 25, 2026
Residual lung abnormality following COVID-19 hospitalisation is characterised by biomarkers of epithelial injuryIain Stewart, Joseph Jacob, Joanna C Porter, et al.
The Lancet. Respiratory Medicine|April 18, 2023
Effects of sleep disturbance on dyspnoea and impaired lung function following hospital admission due to COVID-19 in the UK: a prospective multicentre cohort studyCallum Jackson, Iain D Stewart, Tatiana Plekhanova, et al.
International Journal of Epidemiology|October 21, 2024
Cohort Profile: Post-Hospitalisation COVID-19 (PHOSP-COVID) studyOmer Elneima, Hamish J C McAuley, Olivia C Leavy, et al.
ERJ Open Research|October 1, 2024
1-year health outcomes associated with systemic corticosteroids for COVID-19: a longitudinal cohort studyOlivia C Leavy, Richard J Russell, Ewen M Harrison, et al.
American Journal of Respiratory and Critical Care Medicine|December 2, 2022
Residual Lung Abnormalities after COVID-19 Hospitalization: Interim Analysis of the UKILD Post-COVID-19 StudyIain Stewart, Joseph Jacob, Peter M George, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|April 12, 2026
Investigating prognostic classifications of pre-existing multiple long-term conditions for health outcomes one-year after COVID-19 hospitalisation: a UK prospective observational studyLucy E Gardiner, Daniel Lozano-Rojas, Nikki Smith, et al.
Nature Genetics|May 21, 2025
Genome-wide association study of long COVIDVilma Lammi, Tomoko Nakanishi, Samuel E Jones, et al.
The New England Journal of Medicine|June 17, 2026
Cefazolin for Methicillin-Susceptible <i>Staphylococcus aureus</i> Bacteremia, Todd C Lee, Lauren A Barina, et al.
Pageof 36

Showing results (351-360 of 358) with videos related to

Sort By:
Pageof 36
You have reached the last page of results.This site can display upto 358 results.
Ebiomedicine|January 25, 2026
Residual lung abnormality following COVID-19 hospitalisation is characterised by biomarkers of epithelial injuryIain Stewart, Joseph Jacob, Joanna C Porter, et al.
The Lancet. Respiratory Medicine|April 18, 2023
Effects of sleep disturbance on dyspnoea and impaired lung function following hospital admission due to COVID-19 in the UK: a prospective multicentre cohort studyCallum Jackson, Iain D Stewart, Tatiana Plekhanova, et al.
International Journal of Epidemiology|October 21, 2024
Cohort Profile: Post-Hospitalisation COVID-19 (PHOSP-COVID) studyOmer Elneima, Hamish J C McAuley, Olivia C Leavy, et al.
ERJ Open Research|October 1, 2024
1-year health outcomes associated with systemic corticosteroids for COVID-19: a longitudinal cohort studyOlivia C Leavy, Richard J Russell, Ewen M Harrison, et al.
American Journal of Respiratory and Critical Care Medicine|December 2, 2022
Residual Lung Abnormalities after COVID-19 Hospitalization: Interim Analysis of the UKILD Post-COVID-19 StudyIain Stewart, Joseph Jacob, Peter M George, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|April 12, 2026
Investigating prognostic classifications of pre-existing multiple long-term conditions for health outcomes one-year after COVID-19 hospitalisation: a UK prospective observational studyLucy E Gardiner, Daniel Lozano-Rojas, Nikki Smith, et al.
Nature Genetics|May 21, 2025
Genome-wide association study of long COVIDVilma Lammi, Tomoko Nakanishi, Samuel E Jones, et al.
The New England Journal of Medicine|June 17, 2026
Cefazolin for Methicillin-Susceptible <i>Staphylococcus aureus</i> Bacteremia, Todd C Lee, Lauren A Barina, et al.
Pageof 36